Cargando…

Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma

The immunological significance of autophagy in the tumor microenvironment remains unclear. To explore the relationship between autophagy and anti-tumor immune responses, we investigated the expression of autophagy-related proteins and infiltration of immune cells using immunohistochemistry (IHC). Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakakura, Koichi, Takahashi, Hideyuki, Kaira, Kyoichi, Toyoda, Minoru, Oyama, Tetsunari, Chikamatsu, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317780/ https://www.ncbi.nlm.nih.gov/pubmed/25338734 http://dx.doi.org/10.1111/cas.12559

Ejemplares similares

Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages
por: Takahashi, Hideyuki, et al.
Publicado: (2016)

AKT3 is a key regulator of head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy
por: Takahashi, Hideyuki, et al.
Publicado: (2016)

Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Clinical significance of topoisomerase‐II expression in patients with advanced non‐small cell lung cancer treated with amrubicin
por: Sakurai, Reiko, et al.
Publicado: (2020)

Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report
por: KAYAKABE, MIKIKO, et al.
Publicado: (2014)

Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma
por: Togo, Maria, et al.
Publicado: (2020)

Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017)

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
por: Bilguun, Erkhem-Ochir, et al.
Publicado: (2020)

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
por: Miura, Yosuke, et al.
Publicado: (2017)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma
por: Imai, Hisao, et al.
Publicado: (2020)

Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
por: Mito, Ikko, et al.
Publicado: (2021)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma
por: Imai, Hisao, et al.
Publicado: (2019)

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
por: Kaira, Kyoichi, et al.
Publicado: (2013)

Prospective observational study of carbon‐ion radiotherapy for non‐squamous cell carcinoma of the head and neck
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
por: Tada, Hiroe, et al.
Publicado: (2020)

In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms
por: Yamada, Kanae, et al.
Publicado: (2021)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Dilemma Concerning the Differential Diagnosis of Hematological Malignancy and Bone Metastasis Arising from Lung Cancer
por: Kaira, Kyoichi
Publicado: (2022)

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung
por: Ohtaki, Yoichi, et al.
Publicado: (2021)

Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature
por: Saito, Yasuyuki, et al.
Publicado: (2017)

Epiregulin as a therapeutic target in non-small-cell lung cancer
por: Sunaga, Noriaki, et al.
Publicado: (2015)

Oral findings during follow-up of nasopharyngeal squamous cell carcinoma treatment: A case report
por: Musha, Atsushi, et al.
Publicado: (2021)

Overview of immunology of oral squamous cell carcinoma
por: Sathiyasekar, Anisha Cynthia, et al.
Publicado: (2016)

Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung
por: Xue, Qi, et al.
Publicado: (2001)

Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma
por: Ohshima, Yasuhiro, et al.
Publicado: (2016)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019)

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations
por: Imai, Hisao, et al.
Publicado: (2021)

Clinical significance of primary prophylactic pegylated‐granulocyte‐colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non‐small cell lung cancer
por: Mouri, Atsuto, et al.
Publicado: (2019)

Value of (18)F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment
por: Oriuchi, Noboru, et al.
Publicado: (2022)

Advanced Research on Immune Checkpoint Inhibitor Therapy
por: Imai, Hisao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_22miq0953c9h5n4pp7etftpntt